A Proof-of-concept Study to Evaluate the Benefit From add-on Therapy With Montelukast Versus Salmeterol in Children With Asthma Carrying the Arg/Arg-16 beta2-receptor Genotype.
Phase of Trial: Phase III
Latest Information Update: 01 Apr 2013
At a glance
- Drugs Montelukast (Primary) ; Salmeterol/fluticasone propionate
- Indications Asthma
- Focus Therapeutic Use
- 31 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ISRCTN: Current Controlled Trials record.
- 23 Feb 2009 Status changed from recruiting to active, no longer recruiting, based on information from ClinicalTrials.gov.
- 01 May 2008 New trial record.